Advertisement
Advertisement

EW

EW logo

Edwards Lifesciences Corp

76.45
USD
+0.27
+0.35%
Jul 18, 15:59 UTC -4
Closed
exchange

After-Market

76.75

+0.30
+0.39%

Edwards Lifesciences Corp Profile

About

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.

Info & Links

CEO

Bernard J. Zovighian

Headquarters

ONE EDWARDS WAY
IRVINE, CA 92614, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.edwards.com

Auditor

PricewaterhouseCoopersLLP

Share holders

7,197

Employees

15,800

Edwards Lifesciences Corp Statistics

Valuation Measures

Market Capitalization2

45.02B

Enterprise Value

42.48B

Enterprise Value/EBITDA(ttm)

26.92

Price to Earnings Ratio(ttm)

30.02

Price to Sales(ttm)

8.27

Price to Book(mrq)

4.50

Price to Cash(ytd)

28.58

Profitability

Gross Margin(ttm)

79.51%

Operating Margin(ttm)

28.04%

Profit Margin(ttm)

76.67%

Return on Equity(ttm)

16.62%

Return on Invested Capital(ttm)

14.65%

Return on Assets(ttm)

12.64%

Income Statement

Revenue(ttm)

5.52B

Revenue Per Share(ttm)

9.41

Gross Profit(ttm)

4.39B

EBITDA(ttm)3

1.58B

Net Income Available to Common(ttm)

4.18B

Diluted EPS(ttm)

7.00

Share Statistics

Beta (5Y Monthly)

1.11

52-Week Change

-12.44%

S&P 500 52-Week Change

13.57%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

586.60M

Dividend Yield

0.00%

Float4

584.61M

% Held by Insiders

0.34%

% Held by Institutions

79.46%

Balance Sheet

Total Cash(mrq)

3.90B

Total Cash Per Share(mrq)

6.65

Total Debt(mrq)

597.80M

Total Debt/Equity(mrq)

5.87%

Current Ratio(mrq)

4.45%

Quick Ratio(mrq)

3.66%

Book Value Per Share(mrq)

17.39

Cash Flow

Operating Cash Flow Per Share(ytd)

0.48

Free Cash Flow(ytd)

224.40M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement